PMDD and Histamine: Is There a Connection?
- Jul 6
- 11 min read
For about ten days every month, everything feels pointless. Not sad, not stressed, just a flat, heavy, hopeless version of yourself that cannot be explained by anything happening in your life. You parent through it, work through it, hold yourself together on the outside while barely surviving the inside. And then your period arrives, and within hours or a day or two, you feel like yourself again.
If this sounds familiar, what you are describing is not a personality trait, not a mental health disorder, and not a sign that you cannot cope with your life. It is a physiological condition called premenstrual dysphoric disorder, or PMDD. And it is one of the most under-diagnosed and most misunderstood conditions in women's health.
PMDD is not severe PMS. It is a distinct, physiological condition driven by how the brain responds to normal hormonal fluctuations in the luteal phase. And for some women, histamine is a significant part of that picture.
What PMDD Actually Is
PMDD is characterised by severe mood, cognitive, and physical symptoms that emerge in the luteal phase of the menstrual cycle, typically in the one to two weeks before menstruation, and resolve within a few days of bleeding beginning. The resolution is often rapid and striking, which is one of the features that distinguishes PMDD from other mood disorders.
The symptom picture can include profound low mood or hopelessness, intense irritability or rage that feels disproportionate and frightening, severe anxiety, difficulty concentrating, fatigue that makes basic functioning an enormous effort, and a pervasive sense that nothing matters and nothing will improve. These symptoms are cyclical and predictable, tied to the luteal phase, and distinct from how the woman feels in the rest of her cycle.
What makes PMDD particularly isolating is the cognitive dissonance it creates. A woman can know, intellectually, that her life is fine, that her children are loved, that her relationships are good, and still be unable to access that knowledge in any way that helps. The gap between how things look and how they feel is one of the hallmarks of the condition and one of the most distressing aspects of living with it.
A 2024 Oxford University study estimated that approximately 31 million women globally may be living with PMDD. It is not caused by abnormal hormone levels. Research has consistently shown that women with PMDD have normal levels of oestrogen and progesterone throughout their cycles. The distinguishing feature is not the hormones themselves but how the brain and nervous system respond to them.
The Biology Behind PMDD: What the Research Shows
Understanding PMDD requires looking at what happens in the brain during the luteal phase, not just what is happening hormonally.
Allopregnanolone and GABA
After ovulation, progesterone rises and is converted in the brain to a neurosteroid called allopregnanolone, or ALLO. In most women, ALLO has a calming, GABA-enhancing effect on the nervous system. It helps to quiet the brain's stress response and supports emotional regulation.
In women with PMDD, the brain's response to ALLO appears to be fundamentally different. Rather than producing its usual calming effect, fluctuating ALLO levels in the luteal phase trigger the opposite response in some women, activating rather than quieting the stress and anxiety systems. This paradoxical sensitivity to a normally calming neurosteroid is now considered one of the central mechanisms of PMDD.
Studies have shown that reduced availability of serotonin is also implicated, alongside genetic and epigenetic modifications of hormonal and neurotransmitter pathways. Inflammation also plays a role.
Serotonin Sensitivity
Oestrogen influences serotonin transporter activity and serotonin receptor expression. In women with PMDD, the sensitivity of the serotonin system to luteal phase hormonal fluctuations appears to be heightened, contributing to the mood disruption and emotional dysregulation of the condition. This is one reason SSRIs, which increase serotonin availability, are used as pharmaceutical treatments for PMDD.
The Histamine Connection: An Emerging Piece of the Puzzle
Alongside the established mechanisms of GABA dysregulation and serotonin sensitivity, there is a growing body of research pointing to histamine as a potentially significant contributor to PMDD symptoms in some women. It is important to say clearly that direct clinical research on the histamine-PMDD relationship is still emerging, and there are currently no published trials specifically investigating histamine levels in PMDD. What exists is a compelling body of mechanistic evidence from adjacent areas of research that supports this connection as a plausible and clinically relevant hypothesis.
Oestrogen, Mast Cells, and Histamine
Histamine is not only an allergy mediator. In the body it functions as an inflammatory signal, a digestive regulator, and a neurotransmitter in the brain. It is produced primarily by mast cells, which are immune cells distributed throughout the body including in the reproductive tract, gut, and brain.
Oestrogen directly stimulates mast cells to release histamine. Research published in Frontiers in Immunology has documented the role of female sex hormones in mast cell behaviour, confirming that oestrogen activates mast cells while progesterone tends to have a stabilising effect. This means that as oestrogen rises in the follicular phase and again in the early luteal phase, histamine activity rises with it.
The relationship is bidirectional. Histamine in turn stimulates the ovaries to produce more oestrogen. High oestrogen drives higher histamine, and high histamine drives higher oestrogen. For women whose ability to clear histamine is impaired, this cycle can produce a significant accumulation of histamine in the luteal phase.
How Histamine Affects the Brain and Mood
In the central nervous system, histamine acts as an excitatory neurotransmitter. It promotes wakefulness and arousal, influences the stress response, and modulates the activity of serotonin, dopamine, and GABA. Excess histamine in the brain can produce anxiety, agitation, restlessness, racing thoughts, and a wired, desperate quality of distress that is distinct from classical depression.
For women in the luteal phase who are already experiencing serotonin sensitivity and GABA dysregulation, elevated histamine adds another layer of neurological disruption. The result can be a symptom picture that is more intense, more agitated, or more difficult to treat than PMDD alone might produce.
The DAO Enzyme and Histamine Clearance
The primary enzyme responsible for breaking down histamine in the gut is diamine oxidase, or DAO. When DAO is insufficient or its activity is impaired, histamine accumulates rather than being cleared. DAO production depends on adequate levels of vitamin B6, copper, and vitamin C. Significantly, oestrogen itself can suppress DAO activity, which compounds the histamine accumulation in the luteal phase when oestrogen is elevated.
Gut dysbiosis is another factor that impairs histamine clearance. Certain bacteria produce histamine rather than clearing it, and a microbiome that is dysbiotic tends toward higher histamine production and lower DAO activity. This is one reason gut health is clinically relevant to the PMDD and histamine picture.
"What I find clinically is that the women with the most severe and treatment-resistant PMDD presentations often have additional features that suggest histamine is part of their picture. Premenstrual migraines, sensitivity to wine or aged foods, skin reactions, a particularly agitated or anxious rather than simply depressed quality to their luteal phase. These are not diagnostic of histamine involvement, but they raise it as a worthwhile area to explore. The histamine-oestrogen cycle is well established in the adjacent research, and for some women addressing histamine clearance alongside the core hormonal work makes a huge difference to how the luteal phase feels."
- Gemma Knaap, Naturopath (BHSc Naturopathy, Certified Natural Fertility Educator, Gut Microbiome Analyst) | Southernwood Apothecary & Clinic
Signs That Histamine May Be Part of Your PMDD Picture
Not every woman with PMDD will have obvious signs of histamine excess. The histamine connection is one piece of a complex picture, not a universal feature. But certain patterns suggest it may be relevant and worth investigating:
Premenstrual migraines or headaches that worsen in the luteal phase.
Sensitivity to histamine-rich foods such as wine, beer, aged cheeses, fermented foods, processed meats, and vinegar, particularly if reactions feel cyclically worse premenstrually.
Skin symptoms including flushing, hives, or eczema that flare premenstrually.
Nasal congestion or sinus symptoms that worsen in a cyclical pattern.
An agitated, anxious, wired, or restless quality to luteal phase symptoms rather than simply flat or low mood.
A history of IBS or gut dysbiosis which impairs histamine clearance via reduced DAO activity.
The absence of these features does not rule out histamine involvement. But their presence alongside PMDD strengthens the case for exploring this pathway as part of a comprehensive assessment.
PMDD in Perimenopause: Why It Can Get Worse
For women who have always had difficult luteal phases but find that symptoms are worsening in their late 30's or 40's, perimenopause is a significant contributor.
As progesterone begins to decline in perimenopause, often before oestrogen does, the GABA-calming effect of allopregnanolone is progressively reduced. The luteal phase becomes less well buffered hormonally, and the sensitivity to hormonal fluctuations that underlies PMDD is amplified. At the same time, oestrogen becomes more erratic, with periods of relative excess that drive higher histamine activity. What may have been manageable in the early reproductive years can become genuinely debilitating in perimenopause, not because the woman has changed but because the hormonal environment has shifted significantly.
Women in this group often describe a slow erosion rather than a sudden change. The weeks they feel like themselves becoming fewer. This pattern is not burnout and it is not depression in the traditional sense. It is the brain and nervous system responding to a progressively more unstable hormonal environment, and it is both understandable and addressable.
A Whole-Person Approach to PMDD
PMDD is complex enough that most women benefit from both medical and naturopathic support, and neither should be positioned as a replacement for the other. A GP can rule out other conditions, consider pharmaceutical options including SSRIs used luteal phase-only, or discuss hormonal interventions where appropriate. For severe PMDD, these conversations are important and sometimes urgent. Naturopathic support addresses the underlying biological environment that medical treatment does not cover. This includes:
Assessing and supporting GABA and serotonin pathways through targeted nutritional support including magnesium, B6, zinc, and tryptophan-supporting nutrients.
Addressing histamine clearance and mast cell stabilisation through gut microbiome support, DAO support nutrients, and where relevant, a temporary reduction in high-histamine dietary inputs while the underlying gut and hormonal picture is addressed.
Supporting oestrogen metabolism and clearance to reduce the oestrogen excess that drives both mast cell activation and histamine accumulation.
Nervous system regulation including cortisol management, sleep support, and strategies that reduce the overall load on a nervous system that is already more sensitive to hormonal fluctuations.
Hormonal balance in the luteal phase addressing progesterone quality and ALLO production where these are impaired.
PMDD is one of the conditions where the layered, whole-person approach of naturopathic medicine is most relevant, precisely because the drivers are layered and interact with each other in ways that a single intervention rarely resolves.
What This Means for You
If you spend part of every month barely surviving it and the rest of it dreading when it will come back, you deserve to understand why it keeps happening and to have support that actually addresses the full picture.
PMDD is real, it is physiological, and it is not who you are. It is what your nervous system and brain chemistry are doing in response to your hormonal cycle. And when that response is understood and supported comprehensively, the luteal phase can change significantly.
If you would like to explore this with someone who will see you as a whole person, Telehealth consultations are available across Australia, or in person at my Albany clinic.
Frequently Asked Questions
What is PMDD and how is it different from PMS?
Premenstrual dysphoric disorder (PMDD) is a severe, cyclical condition characterised by significant mood disruption, cognitive impairment, and physical symptoms in the luteal phase of the menstrual cycle that resolve when menstruation begins. It is distinct from PMS in both severity and mechanism. PMS involves milder premenstrual symptoms that may be uncomfortable but do not significantly impair daily functioning. PMDD involves symptoms severe enough to affect the ability to work, parent, maintain relationships, and function. The resolution of symptoms with the onset of menstruation is a diagnostic hallmark. PMDD is estimated to affect 3.2% of women of reproductive age using confirmed diagnostic criteria.
What causes PMDD?
PMDD is not caused by abnormal hormone levels. Women with PMDD have normal oestrogen and progesterone throughout their cycles. The distinguishing feature is how the brain and nervous system respond to normal luteal phase hormonal fluctuations. The current research points to altered sensitivity of the GABA system to allopregnanolone, a neurosteroid derived from progesterone, as a central mechanism. Serotonin sensitivity, inflammation, and genetic factors are also involved. The result is a brain that responds paradoxically to hormonal fluctuations that most women tolerate without significant symptoms.
Is there a connection between histamine and PMDD?
The connection is emerging and mechanistically plausible, though direct clinical research on histamine levels in PMDD is still limited. What the adjacent research shows is that oestrogen stimulates mast cells to release histamine, and histamine in turn stimulates oestrogen production. In the luteal phase, when oestrogen is elevated, histamine activity rises with it. For women whose histamine clearance is impaired, whether due to low DAO enzyme activity, gut dysbiosis, or nutritional deficiencies, this accumulation can amplify the neurological and mood symptoms of PMDD. Histamine is an excitatory neurotransmitter in the brain, and excess histamine can produce agitation, anxiety, and mood disruption that compounds the core PMDD picture.
How do I know if histamine is part of my PMDD?
There is no single definitive test for histamine involvement in PMDD. Signs that may suggest it is a relevant factor include premenstrual migraines or headaches, sensitivity to histamine-rich foods such as wine, aged cheese, and fermented foods, skin flushing or hives that worsen premenstrually, nasal congestion that follows a cyclical pattern, a history of gut dysbiosis or IBS, and a particularly agitated or wired quality to luteal phase symptoms rather than simply low mood. These features are not diagnostic, and their absence does not rule out histamine involvement. Professional assessment of the full hormonal and gut health picture is the most useful starting point.
Can PMDD get worse in perimenopause?
Yes, and for many women it does. As progesterone begins to decline in perimenopause, the calming, GABA-enhancing effect of allopregnanolone is progressively reduced. The luteal phase becomes less well buffered hormonally, and sensitivity to hormonal fluctuations that underlies PMDD is amplified. At the same time, oestrogen becomes more erratic, with periods of relative excess that drive higher histamine activity. Women who had manageable premenstrual symptoms in their 30's can find them becoming significantly more severe in their 40's. This is not a reflection of worsening mental health. It is a hormonal change that is both understandable and addressable with appropriate support.
What are the treatment options for PMDD?
PMDD is best managed with a combination of medical and naturopathic support. Medical options will rule out other underlying pathologies and explore pharmaceutical treatment options. Naturopathic support addresses the underlying hormonal, neurological, gut, and nutritional drivers that medical treatment does not, including GABA and serotonin support, histamine clearance, gut health, oestrogen metabolism, nervous system regulation, and overall inflammatory load. Both approaches have a role and neither excludes the other.
Can a naturopath help with PMDD?
Yes. A naturopath can assess the full hormonal, neurological, gut, and nutritional picture and design a treatment strategy that addresses the specific drivers present for the individual. This is particularly relevant for PMDD because the condition involves multiple interacting mechanisms, and addressing only one without looking at the others produces limited outcomes. Naturopathic care works best alongside medical management, not instead of it, particularly for severe presentations. Telehealth consultations are available across Australia, or in person in Albany, WA.
About the Author
Gemma Knaap is a naturopath practicing in Albany, Western Australia and via Telehealth across Australia. She specialises in women's hormonal health, gut health, fertility, and reproductive wellbeing. She holds a Bachelor of Health Science in Naturopathy and is a Certified Natural Fertility Educator and Gut Microbiome Analyst.
References
Reilly, T.J. et al. (2024). Prevalence of premenstrual dysphoric disorder: a systematic review and meta-analysis. Journal of Psychiatric Research. Cited in: Oxford University News, January 2024. https://www.ox.ac.uk/news/2024-01-30-new-data-shows-prevalence-premenstrual-dysphoric-disorder
Hantsoo, L. et al. (2022). Toward understanding the biology of premenstrual dysphoric disorder: from genes to GABA. Neuroscience and Biobehavioral Reviews. https://doi.org/10.1016/j.neubiorev.2023.105126
Faculty Reviews. (2022). Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC9066446/
Frontiers in Psychiatry. (2024). Premenstrual syndrome: new insights into etiology and review of treatment methods. https://doi.org/10.3389/fpsyt.2024.1363875
Frontiers in Pharmacology. (2025). Using estrogen and progesterone to treat premenstrual dysphoric disorder, postnatal depression and menopausal depression. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC11882533/
Zierau, O., Zenclussen, A.C. and Jensen, F. (2012). Role of Female Sex Hormones, Estradiol and Progesterone, in Mast Cell Behavior. Frontiers in Immunology, 3, 169. https://doi.org/10.3389/fimmu.2012.00169
International Association for Premenstrual Disorders (IAPMD). (2024). What Is the Role of Histamine and Mast Cells in PMS and PMDD? https://faq.iapmd.org/en/articles/8057891
The Conversation. (2025). PMDD: social media users claim antihistamines help symptoms. https://theconversation.com/pmdd-social-media-users-claim-antihistamines-help-symptoms-heres-what-the-evidence-says-253587
Briden, L. (2024). The curious link between estrogen and mast cells and histamine. https://www.larabriden.com/the-curious-link-between-estrogen-and-histamine-intolerance/
Briden, L. (2021). The role of histamine and mast cells in PMS and PMDD. https://www.larabriden.com/histamine-intolerance-pms-pmdd/
Comments